Paul Tudor Jones Omega Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$11.33 - $29.38 $538,809 - $1.4 Million
-47,556 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$16.0 - $22.51 $760,896 - $1.07 Million
47,556 New
47,556 $896,000

Others Institutions Holding OMGA

# of Institutions
58
Shares Held
43.4M
Call Options Held
25.8K
Put Options Held
7K
View Full List

About Omega Therapeutics, Inc.

OMGA Quotes by TradingView
  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $37.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email